Leverage magnifies whatever a business is already doing. This scan looks for the unfavourable case: debt at four times EBITDA or more, earnings declining year-over-year, and EBITDA margins shrinking at the same time. Debt service is a fixed obligation while earnings are not, so a company carrying that ratio into a downturn has less and less room between what it earns and what it owes.
Matches as of · delayed 14 days · Live on Super Pro
| Ticker | Company | Sector | Market cap | Price today | Change today |
|---|---|---|---|---|---|
| MRK | Merck & Co., Inc. | Manufacturing | $327.4B | $133.76 | +0.72% |
| GILD | Gilead Sciences Inc | Manufacturing | $206.6B | $166.43 | -0.06% |
| PFE | Pfizer Inc. | Manufacturing | $157.0B | $27.54 | 0.00% |
| AMT | American Tower Corporation | Finance, Insurance, And Real Estate | $84.0B | $184.52 | +1.86% |
| CI | The Cigna Group | Finance, Insurance, And Real Estate | $71.9B | $270.89 | -0.79% |
Showing the top 5 of 188 matches. See all matches on the Super Pro plan.
This scan uses filters from the Super Pro plan. Load it as a preset, adjust any filter, and run it against live market data.
View pricing